ABSL Pure Value fund, one of the investor favorite funds, now gaining momentum. It has 43% exposure to top-performing stocks, helping it gain 21% in the last 3 months. One can look at investing in this fund, which is carrying about 4.5% risk on today’s NAV.
Pharma Funds continue their dream run, having added 2% more profits to their already locked 15% profits. Risks on MF NAV’s have started coming down from 5 to 4.50%, this is both a caution and an advantage. Play safe.